Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.3232
+0.0075 (2.38%)
At close: May 12, 2025, 4:00 PM
0.3300
+0.0068 (2.10%)
After-hours: May 12, 2025, 7:07 PM EDT
Renovaro Market Cap
Renovaro has a market cap or net worth of $56.15 million as of May 12, 2025. Its market cap has decreased by -80.16% in one year.
Market Cap
56.15M
Enterprise Value
63.02M
1-Year Change
-80.16%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $56.15M, a decrease of -77.72%. That is a compound annual growth rate of -20.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 50.20M | -62.17% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |